Vertex Pharmaceuticals Incorporated (VRTX) Profit Margin
Vertex Pharmaceuticals Incorporated (VRTX) gross and net profit margin history with trends. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2016-12-31 | -6.58% |
| 2017-12-31 | 10.59% |
| 2018-12-31 | 68.80% |
| 2019-12-31 | 28.27% |
| 2020-12-31 | 43.70% |
| 2021-12-31 | 30.92% |
| 2022-12-31 | 37.20% |
| 2023-12-31 | 36.68% |
| 2024-12-31 | -4.86% |
| 2025-12-31 | 32.94% |
How VRTX compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| EXEL | Exelixis Inc. | 33.73% |
| LLY | Eli Lilly and Company | 31.67% |
| REGN | Regeneron Pharmaceuticals Inc. | 31.41% |
| GILD | Gilead Sciences Inc. | 28.90% |
| ADMA | ADMA Biologics Inc | 28.80% |
These are five companies in the same sector as VRTX with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Vertex Pharmaceuticals Incorporated Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("VRTX", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | VRTX | $530.45 | +1.25% | 0.56M |
| 3 | ||||
| 4 | ||||
| 5 |